ZKR-74358-23250
4 vaccinations
12 coded responses
45 check-ins
12 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 26-30
- ZIP prefix
- 532 / WI
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
-
2021-01-14
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Mild sore throat.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Thirst — Feeling: Fair · Fatigue or tirednessFree text: Excessive ThirstMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Good · Fatigue or tirednessFree text: Mild sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — day 7, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · ChillsFree text: Mild sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
-
2021-02-02
Survey response — day 21, dose 1MedDRA: Fatigue, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue and sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Dose 2 — Pfizer-BioNTech
- 2021-02-03
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal dreams, Muscular weakness, Thirst — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Intense dreams, muscle weakness, excessive thirstMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Muscular weakness — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Muscle weakness in arm I received shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-05-07
- 2021-08-04
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Pollakiuria — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Nausea, Abdominal painFree text: Frequent urinationMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Injection site induration, Injection site swelling — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessFree text: The swelling is extremely firm at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
- 2021-10-06
-
2021-10-07
Health check-in — day 7, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-14
- 2021-10-21
-
2021-10-28
Survey response — day 28, dose 3MedDRA: Fatigue, Headache, Nasal congestion — Feeling: PoorFree text: More frequent headache, nasal congestion, and fatigue.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-04
- 2021-11-11
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Arthralgia, Asthenia, COVID-19, Chills, Cough, Diarrhoea, Fatigue, Headache, Hypogeusia, Myalgia, Nasal congestion, Nausea, Oropharyngeal pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have covid. Nausea, diarrhea, fever and chills, muscle and joint pain and weakness, fatigue, headache, sore throat, cough, nasal congestion, and decreased sense of taste.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-31
-
2022-09-16
Dose 4 — Pfizer-BioNTech
- 2022-09-30
- 2022-09-30
-
2022-10-07
Survey response — day 21, dose 4MedDRA: Decreased appetite, Pyrexia, Rhinorrhoea — Feeling: GoodFree text: Fever and sniffles with loss of appetiteMedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-23
- 2022-10-28
- 2022-12-18
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-17 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild sore throat.
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Excessive Thirst
Systemic reaction (other): Mild sore throat
Release 2 — day 7, dose 1
Systemic reaction (other): Mild sore throat
Release 3 — day 21, dose 1
Symptoms: Fatigue and sore throat
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Intense dreams, muscle weakness, excessive thirst
Systemic reaction (other): Muscle weakness in arm I received shot
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Frequent urination
Systemic reaction (other): The swelling is extremely firm at injection site
Release 10 — day 28, dose 3
Symptoms: More frequent headache, nasal congestion, and fatigue.
Release 10 — 3 months, dose 3
Symptoms: I have covid. Nausea, diarrhea, fever and chills, muscle and joint pain and weakness, fatigue, headache, sore throat, cough, nasal congestion, and decreased sense of taste.
Release 12 — day 21, dose 4
Symptoms: Fever and sniffles with loss of appetite
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Abnormal dreams | ✓ | ✓ | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pollakiuria | · | · | ✓ |
| SRO | Thirst | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release